Pan Hong H - OmicsDI

Show results for

Unknown (869)
Proteomics (36)
Transcriptomics (21)
Metabolomics (8)
Genomics (4)

Organisms

Homo sapiens (27)
Bartonella quintana JK 31 (14)
Bombyx mori (14)
Onchocerca volvulus (14)
Klebsiella pneumoniae (14)
Musca domestica (14)
Brugia malayi (14)
Schizosaccharomyces pombe (14)
Oryza sativa (14)
Cnidaria (14)
Streptomyces coelicolor A3(2) (14)
Sus scrofa (14)
Human immunodeficiency virus 1 (14)
Oryza sativa Indica Group (14)
Eukaryota (14)
Sinorhizobium meliloti BL225C (14)
Vitis (14)
Sus scrofa domesticus (14)
Ostreococcus tauri (14)
Mus musculus (9)
Klebsiella pneumoniae subsp. pneumoniae MGH 78578 (1)
Cucumis sativus (1)
Pan troglodytes (1)
Xenopus laevis (1)
Nicotiana tabacum (1)
Oryza sativa Japonica Group (1)
Danio rerio (1)
Bungarus sindanus (1)
Mus sp. (1)
Toxoplasma gondii RH (1)

Repository

biostudies-arrayexpress (23)
iProX (20)
pride (14)
MetaboLights (8)
EGA (2)
MassIVE (2)

Tissue

Cell culture (4)
Liver (2)
Colon (2)
Microglial cell activation (1)
Stomach lumen (1)
Stomach (1)
Macrophage (1)
Stem cell (1)
Hepatocyte (1)
Lung (1)
Permanent cell line cell (1)
Epithelial cell (1)

Disease

Colon cancer (2)
Retinal degeneration (1)
Stomach carcinoma (1)
COVID-19 (1)

Technology Type

Mass Spectrometry (14)
Shotgun proteomics (6)
Mass spectrometry assay (5)
Bottom-up proteomics (5)
Mass spectrometry (3)
Gel-based experiment (3)
Illumina HiSeq 2000 (1)
SWATH MS (1)
Data-dependent acquisition (1)
Top-down proteomics (1)
Affinity purification coupled with mass spectrometry proteomics (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (3)
Liquid Chromatography MS - positive - reverse phase (3)
Q Exactive (2)
Liquid Chromatography MS - (2)
NextSeq 2000 (1)
BGISEQ-500 (1)
Illumina NovaSeq 6000 (1)
LTQ Orbitrap Elite (1)
Liquid Chromatography MS - alternating – hilic (1)
Liquid Chromatography MS - negative (1)
Liquid Chromatography MS - positive (1)
Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)

Publication Date

2025 (12)
2026 (6)
2005 (6)
2022 (5)
2010 (4)
2024 (4)
2012 (3)
2011 (3)
2023 (3)
2020 (3)
2014 (2)
2015 (1)
2008 (1)
2006 (1)
2019 (1)
2017 (1)

CHEBI ID

CHEBI:16335 (3)
CHEBI:165576 (2)
CHEBI:168472 (2)
CHEBI:16796 (2)
CHEBI:145277 (2)
CHEBI:86595 (2)
CHEBI:87248 (2)
CHEBI:68616 (2)
CHEBI:73218 (2)
CHEBI:70989 (2)
CHEBI:74327 (2)
CHEBI:43065 (2)
CHEBI:24823 (2)
CHEBI:75168 (2)
CHEBI:75108 (2)
CHEBI:82984 (2)
CHEBI:27781 (2)
CHEBI:76308 (2)
CHEBI:24813 (2)
CHEBI:68830 (2)
CHEBI:36005 (2)
CHEBI:43580 (2)
CHEBI:27823 (2)
CHEBI:73026 (2)
CHEBI:64489 (2)
CHEBI:7274 (2)
CHEBI:72663 (2)
CHEBI:28875 (2)
CHEBI:28728 (2)
CHEBI:28842 (2)

Metabolite Name

Riboflavin (3)
Hypoxanthine (3)
Guanosine (3)
4',5,8-Trihydroxyflavanone (2)
Phlorin (2)
Cotinine glucuronide (2)
27-Norcholestanehexol (2)
6-Oxopiperidine-2-carboxylic acid (2)
3-Dehydroxycarnitine (2)
Tryptophyl-Valine (2)
LysoPE(18:1(9Z)/0:0) (2)
Quinolinic acid (2)
Linatine (2)
L-Dopa (2)
Phenylalanyl-Isoleucine (2)
9,10-DHOME (2)
5-Hydroxyindoleacetic acid (2)
Piperidine (2)
Prolylhydroxyproline (2)
Oleamide (2)
Salicylic acid (2)
Guanine (2)
Inosine (2)
Uridine (2)
ST 24:1 (1)
SQDG 15:0_16:1 (1)
PS O-10:0_16:0 (1)
PS 11:0_18:2 (1)
PA 9:0_14:1 (1)
NAOrn 11:0/20:1 (1)

Study type

Transcription profiling by array (14)
RNA-seq of coding RNA (3)
Unknown experiment type (2)
ChIP-chip by tiling array (1)
Transcription profiling by RT-PCR (1)
ChIP-seq (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2025 (160)
2024 (140)
2022 (111)
2023 (110)
2021 (82)
2020 (66)
2019 (37)
2018 (30)
2015 (26)
2026 (24)
2016 (23)
2017 (22)
2014 (21)
2010 (7)
2013 (7)
2012 (6)
2005 (6)
2011 (5)
2008 (2)
2009 (2)
2007 (2)
2006 (1)
2004 (1)
2000 (1)

Lab affiliation

University/Hospital: the Second Clinical Medical College of Jinan University (Shenzhen People’s Hospital) Street Name & Number: No. 1017, North of Dongmen Road, Shenzhen City, Guangdong Province 518020, China (1)
The Laboratory of Molecular Genetics, National Heart Lung and Blood Institute (1)
College of Pharmacy, Jinan University, Guangzhou, China (1)
HKUST (1)
Department of Hepatobiliary Surgery of the affiliated Taizhou People's Hospital of Nanjing Medical University, 225300 Taizhou, Jiangsu Province, China (1)
The Hong Kong University of Science and Technology (1)
Chemical and Biological Engineering, The Hong Kong University of Science and Technology (HKUST), Hong Kong (lab head) (1)
Department of Gastrointestinal Surgery, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen (1)
1 Department of Clinical Nutrition, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China 2 Clinical Research Center, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China (1)
School of Optometry, The Hong Kong Polytechnic University, Hong Kong (1)
Department of Microbiology, The University of Hong Kong, Hong Kong, SAR, China (1)
Center for Cell Lineage and Development, CAS Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, GIBH-HKU Guangdong-Hong Kong Stem Cell and Regenerative Medicine Research Centre, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China. (1)
Zhejiang University (1)
Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK. UCL Cancer Institute, University College London, London, United Kingdom. Cancer Research UK City of London Centre. GSK (1)

Previous page
1 / 94
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 94
Next page

Sort by:

Relevance

Page size

Occlusion enhanced pan-cancer classification via deep learning.

Not available

S-EPMC11308240 | biostudies-literature

Populational pan-ethnic screening panel enabled by deep whole genome sequencing.

Not available

S-EPMC10661700 | biostudies-literature

Human Angiotensin-Converting Enzyme 2-Specific Benzothiazole Allosteric Inhibitor against Pan-Sarbecoviruses

Emerging SARS-CoV-2 variants of concern (VOCs) have demonstrated exceptional transmissibility and a strong dependence on the cellular receptor human angiotensin-converting enzyme 2 (hACE2). In this study, we present MB-32, a benzothiazole-based small molecule allosteric inhibitor of hACE2, w...

ORGANISM(S): Homo sapiens (Human) Sarbecovirus

2026-05-01 | PXD075140 | Pride

Pan-cancer analysis of differential DNA methylation patterns.

Not available

S-EPMC7579968 | biostudies-literature

Pan PPAR agonist stimulation of induced MSCs produces extracellular vesicles with enhanced renoprotective effect for acute kidney injury.

Not available

S-EPMC10763307 | biostudies-literature

Proteomic study of baicalein effects on LPS-primed BV2 microglia

To comprehensively study the intracellular signaling changes and explore the underlying mechanisms of baicalein-mediated microglial responses, we employed systemic proteomic approach, using target-free SWATH mass spectra (SWATH-MS), focusing on intracellular proteins. BV2 cells were treated with LPS...

ORGANISM(S): Mus musculus (Mouse)

2022-02-14 | PXD030447 | Pride

Baicalein Microglia

Pan-chloroplast genomes for accession-specific marker development in Hibiscus syriacus.

Not available

S-EPMC10899175 | biostudies-literature

Global gene expression change in the cerebellum of Niemann-Pick disease type C mice with deletion of Ccl3 or Purkinje neuron-specific NPC1 rescue

Macrophage inflammatory protein 1alpha/CCL3 protein is a known pro-inflammatory cytokine that can mediate chemotaxis of monocytes and promote cell degranulation. Ccl3 gene expression is elevated in the CNS and visceral tissue of many lysosomal storage disorders. The deletion of Ccl3 in a mouse model...

ORGANISM(S): Mus musculus

2012-04-16 | E-GEOD-36119 | biostudies-arrayexpress

PIM1 Attenuates Innate Immunity to Foster Coronavirus Replication through Ubiquitin Ligase β-TrCP-Mediated IFNAR1 Degradation.

Not available

S-EPMC12499414 | biostudies-literature

Incorporating High-Risk Individuals Beyond Smoking History Into Lung Cancer Screening in Hong Kong: A Cost-Effectiveness Study.

Not available

S-EPMC12570320 | biostudies-literature

Previous page
1 / 94
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 94
Next page

Sort by:

Relevance

Page size

938 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets